Evidence map›Paper›PMID 26213461›Full record

ArticleDrug design, development and therapy2015

Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients.

Min Liang, Boyun Shi, Jifang Liu, Lu He, Gao Yi, Lin Zhou, Guifang Yu, Xinke Zhou

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Drug design, development and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Min LiangDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Boyun ShiDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Jifang LiuDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Lu HeDepartment of radiotherapy, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Gao YiDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Lin ZhouDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Guifang YuDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Xinke ZhouDepartment of Oncology, The fifth affiliated hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.
Guangzhou Medical University · CNGuangzhou Medical University Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite advances in clinical therapies and technologies, the prognosis for patients with gastric cancer is still poor. The aim of this study is to investigate new predictive markers for prognosis of gastric cancer.

methodsIn this study, we evaluated the expression pattern of PIK3CA in 107 gastric cancer specimens and their adjacent nontumorous tissues. PIK3CA siRNA was synthesized and transfected into gastric cancer cell lines. Colony formation and MTT assays were employed to analyze the cell proliferation. PIK3CA expression was examined by using immunohistochemical analysis and Western blot assay. Transwell invasion assay was used to detect the invasion capability of the cells. Luciferase activity was examined by using 3'-untranslated region luciferase reporter assays.

resultsWe observed that PIK3CA was significantly upregulated in gastric cancer tissues. High expression level of PIK3CA was detectable in 48 (44.86%) of the gastric cancer specimens, and correlated with poor prognosis. In addition, our study indicated that miR203 inhibits cell proliferation and invasion via directly targeting and suppressing the PIK3CA expression. MiR203 expression is downregulated in gastric cancer tissues. Moreover, low expression level of miR203 predicted poor prognosis of gastric patients and induced overexpression of PIK3CA. Our further study also reported that overexpression of miR203 inhibited phosphorylation of AKT, while cotransfection of PIK3CA reversed the effect of miR203.

conclusionOur study suggested a miR203-PIK3CA-AKT signaling pathway in gastric cancer cells. This signaling pathway might play an important role in gastric cancer genesis and development.

Indexed as

Biomarkers, TumorCell Line, TumorCell ProliferationClass I Phosphatidylinositol 3-KinasesDown-RegulationGene Expression Regulation, NeoplasticHumansMicroRNAsNeoplasm InvasivenessPhosphatidylinositol 3-KinasesPrognosisProto-Oncogene Proteins c-aktRNA, Small InterferingSignal TransductionStomach NeoplasmsTransfectionBiomarkers, TumorClass I Phosphatidylinositol 3-KinasesMicroRNAsMIRN203 microRNA, humanPhosphatidylinositol 3-KinasesPIK3CA protein, humanProto-Oncogene Proteins c-aktRNA, Small InterferingAKTgastric cancermiR203PIK3CAprognosis

Identifiers

PMID26213461
PMCPMC4509530
OpenAlexW1723983223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.